Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

NCT05906576 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Infliximab

Sponsor

Taizhou Mabtech Pharmaceutical Co.,Ltd